Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT00538824 · TERMINATED
Trial details
- NCT number
- NCT00538824
- Sponsor
- Weill Medical College of Cornell University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2010-09-22
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.